Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat

Shock

Volumn 4, Issue 3, 1995, Pages 178-186

  Pearson, Julia M ^a   Schultze, A Eric ^a,b   Jean, Paul A ^a   Roth, Robert A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FIBRINOGEN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; NECROSIS; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ALANINE TRANSAMINASE; ANIMALS; BLOOD PLATELETS; ESCHERICHIA COLI; FEMALE; FIBRINOGEN; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LIVER; NECROSIS; NEUTROPHILS; PLATELET COUNT; RATS; RATS, SPRAGUE-DAWLEY; THROMBOCYTOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029366299     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199509000-00005     Document Type: Article

References (33)

1. Hewett JA, Roth RA: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 45:381-411, 1993.
2. Levy E, Path FC, Slusser RJ, Ruebner BH: Hepatic changes produced by a single dose of endotoxin in the mouse: Electron microscopy. Am J Pathol 52:477-502, 1968.
3. Shibayama Y: Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol 151:315-321, 1987.
4. Hewett JA, Schultze AE, VanCise S, Roth RA: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 66:347-361, 1992.
5. Sleeman HK, Hardaway RM: Evaluation of biochemical changes associated with experimental endotoxemia. I. Transaminase activity. Surgery 61:945-950, 1967.
6. Hewett JA, Roth RA: The coagulation system, but not circulating fibrinogen, contributes to liver injury in rats exposed to lipopolysaccharide from Gram-negative bacteria. J Pharmacol Exp Ther 272:53-62, 1995.
7. Margaretten W, McKay DG, Phillips IX: The effect of heparin on endotoxin shock in the rat. Am J Pathol 51:61-68, 1967.
8. Prager RL, Dunn EL, Kirsh MM, Penner JA: Endotoxin-induced intravascular coagulation (DIC) and its therapy. Adv Shock Res 2:277-287, 1979.
9. Walsh PN, Griffin JH: Platelet-coagulant protein interactions in contact activation. Ann NY Acad Sci 370:241-252, 1981.
10. Christenson JT, Sigurdsson GH, Mousawi M, Owunwanne A: Use of indium-111 oxine to study the effects of terbutaline on pulmonary and hepatic platelet sequestration in endotoxin shock. J Physiol Imaging 2:186-191, 1987.
11. Sostman HD, Zoghbi SS, Smith GJW, Carbo P, Neumann RD, Gottschalk A, Greenspan RH: Platelet kinetics and biodistribution in canine endotoxemia. Invest Radiol 18:425-435, 1983.
12. Kramer W, Muller-Berghaus G: Effect of platelet antiserum on the activation of intravascular coagulation by endotoxin. Thromb Res 10:47-70, 1977.
13. Ito T, Asai F, Oshima T, Kobayashi S: Role of activated platelets in endotoxin-induced DIC in rats. Thromb Res 59:735-747, 1990.
14. Wise W, Cook J, Halushka P, Knapp D: Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. Ore Res 46:854-859, 1980.
15. Shibayama Y, Asaka S, Urano T, Araki M, Oda K: Role of neutrophils and platelets in the pathogenesis of focal hepatocellular necrosis in endotoxemia. Exp Toxic Pathol 47:35-39, 1995.
16. Jaeschke H, Farhood A, Smith CW: Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 21:G1051-G1056, 1991.
17. Tiegs G, Niehorster M, Wendel A: Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF-α in galactosamine-sensitized mice. Biochem Pharmacol 40:1317-1322, 1990.
18. Hewett JA, Kunkel SL, Roth RA: Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am J Physiol 265:G1011-G1015, 1993.
19. Wester J, Sixma JJ, Geuze JJ, Heijnen HFG: Morphology of the hemostatic plug in human skin wounds: Transformation of the plug. Lab Invest 41:182-192, 1979.
20. Issekutz AC, Ripley M, Jackson JR: Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest 49.6:716-724, 1983.
21. del Maschio A, Evangelista V, Rajtar G, Chen ZM, Cerletti C, De Gaetano G: Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol 258:H870-H879, 1990.
22. Hosford D, Koltai M, Braquet P: Platelet-activating factor in shock, sepsis and organ failure. In Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer Verlag, 1993, pp 502-512.
23. White SM, Wagner JG, Roth RA: Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats. Toxicol Appl Pharmacol 99:302-313, 1989.
24. Steel RGD, Torrie JH: Principles, Procedures in Statistics. A Biometrical Approach. 2nd ed. New York: McGraw-Hill, 1980, pp 173-175, 542.
25. Piguet PF, Vesin C, Ryser JE, Senaldi G, Grau GE, Tacchini-Cottier F: An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD 11 a- and CD54-dependent interaction with endothelium. Infect Immun 61:4182-4187, 1993.
26. Brown AP, Ng H, Jean PA, Ganey PE, Roth RA: Kupffer cell inactivation protects against lipopolysaccharide-induced hepatic injury despite neutrophil accumulation and tumor necrosis factor-α (TNF-α) release. Toxicologist 1995 (abstract).
27. Endo Y, Nakamura M: Active translocation of platelets into sinusoidal and Disse spaces in the liver in response to lipopolysaccharides, interleukin-1 and tumor necrosis factor. Gen Pharmacol 24:1039-1053, 1993.
28. Harlan JM, Harker LA, Striker GE, Weaver LJ: Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 29:15-26, 1983.
29. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M: Activation of human platelets by C5a-stimulated neutrophils: A role for cathepsin G. Am J Physiol 258:C1100-C1107, 1990.
30. Selak MA, Chignard M, Smith JB: Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 251:293-299, 1988.
31. Renesto P, Chignard M: Tumor necrosis factor-a enhances platelet activation via cathepsin G released from neutrophils. J Immunol 146:2305-2309, 1991.
32. Montrucchio G, Alloatti G, Mariano F, Comino A, Cacace G, Polloni R, De Filippi PG, Emanuelli G, Camussi G: Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. Am J Pathol 142:471-480, 1993.
33. Imura Y, Terashita Z, Nishikawa K: Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988. Life Sci 39:111-117, 1986.